Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Recent advances in gene delivery for structural bone allografts.

Recent advances in gene delivery for structural bone allografts. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Recent advances in gene delivery for structural bone allografts. Abstract Text:

    hani a awadHani A Awad,xinping zhangXinping Zhang,david g reynoldsDavid G Reynolds,robert e guldbergRobert E Guldberg,regis j o'keefeRegis J O'Keefe,edward m schwarzEdward M Schwarz,

    In this paper, we review the progress toward developing strategies to engineer improved structural grafting of bone. Three strategies are typically used to augment massive bone defect repair. The first is to engraft mesenchymal stem cells (MSCs) onto a graft or a biosynthetic matrix to provide a viable osteoinductive scaffold material for segmental defect repair. The second strategy is to introduce critical factor(s), for example, bone morphogenetic proteins (BMPs), in the form of bone-derived or recombinant proteins onto the graft or matrix directly. The third strategy uses targeted delivery of therapeutic genes (using viral and nonviral vectors) that either transduce host cells in vivo or stably transduce cells in vitro for subsequent implantation in vivo. We developed a murine femoral model in which allografts can be revitalized via recombinant adeno-associated virus (rAAV) gene transfer. Specifically, allografts coated with rAAV expressing either the constitutively active BMP type I receptor Alk2 (caAlk2), or the angiogenic factor vascular endothelial growth factor (VEGF) combined with the osteoclastogenic factor receptor activator of NF-kappa B ligand (RANKL) have remarkable osteogenic, angiogenic, and remodeling effects that have not been previously documented in healing allografts. Using histomorphometric and micro computed tomography (muCT) imaging we show that rAAV-mediated delivery of caAlk2 induces significant osteoinduction manifested by a mineralized callus on the surface of the allograft, which resembles the healing response of an autograft. We also demonstrate that the rAAV-mediated gene transfer of the combination of VEGF and RANKL can induce significant vascularization and remodeling of processed structural allografts. By contrast, rAAV-LacZ coated allograft controls appeared similar to necrotic allografts and lacked significant mineralized callus, neovascularization, and remodeling. Therefore, innovations in gene delivery offer promising therapeutic approaches for tissue engineering of structural bone substitutes that can potentially have clinical applications in challenging indications.

    Recent advances in gene delivery for structural bone allografts. Publishing Authors By Initials

    ha awadHA Awad,x zhangX Zhang,dg reynoldsDG Reynolds,re guldbergRE Guldberg,rj o'keefeRJ O'Keefe,em schwarzEM Schwarz,

    For similar surgical procedures, operative: transplantation: transplantation, homologous research abstracts see: surgical procedures, operative: transplantation: transplantation, homologous research

    PUBMED ID PMID:

    MEDLINE DATE:

    Recent advances in gene delivery for structural bone allografts. Journal Published:

    PUBLICATION TYPE: Review

    Journal: Tissue engineering

    VOLUME: 13

    Page Numbers: 1973-85

    Journal Abbreviation: Tissue Eng.

    ISSN: 1076-3279

    DAY: 3

    MONTH: Aug

    YEAR: 2007

    Recent advances in gene delivery for structural bone allografts. Information

    Number of References: 118

    LANGUAGE: eng

    NlmUniqueID: 9505538

    Recent advances in gene delivery for structural bone allografts. Keywords Mesh Terms:

    KEYWORDS: Transplantation, Homologous

    MESH TERMS: trends

    Chemical & Substance for Abstract: Recent advances in gene delivery for structural bone allografts. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Recent advances in gene delivery for structural bone allografts.

    AFFILIATION: Department of Biomedical Engineering, The Center for Musculoskeletal Research, University of Rochester, Rochester, New York 14620, USA. Hani_Awad@urmc.rochester.edu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIEHS

    GRANT: ES011854

    ACRONYM: ES

    MEDLINETA: Tissue Eng

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Recent advances in gene delivery for structural bone allografts Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News